Scholarlink

Background <p>Growing documents suggest combination therapy as an effective tool to treat the resistant cancer cells. Accordingly, in this study, it has been hypothesized that a combination of Vitamin D3(VD) and Itraconazole can inhibit Chronic Myeloid Leukemia(CML) K562 cells in vitro.</p> Methods and results <p>K562 cells were incubated with different concentrations of either VD or Itraconazole either alone or in combination. The results showed that Itraconazole, VD, and combination treatment reduced the cell viability in a time and dose-dependent manner (<i>P</i> &lt; 0.0001). In addition, the apoptosis rate was significantly induced in cells treated with combination drug (<i>P</i> &lt; 0.0001). The Bax/Bcl-2 ratio was increased in treated cells, whereas the subcellular distribution of β-catenin protein was reduced. Morever, the phosphorylation of AKT and p65 were increased, whereas AMPK phosphorylation was decreased in treated cells (<i>P</i> &lt; 0.0001).</p> Conclusion <p>Our results show that VD and Itraconazole synergically inhibit K562 cells viability via activation of AMPK and suppression of AKT function, suggesting that this combinational therapy potentially benefits CML patients.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Vitamin D3 augments cytotoxic effect of Itraconazole on chronic myelogenous leukemia cell line: a synergic effect on AMPK/AKT signaling pathway

  • 期刊论文

  • 发表日期：

    2025年6月16日

查看全文
  • Moein Tahvili,
  • Vahid Nejati,
  • Yaghub Pazhang

摘要

Background

Growing documents suggest combination therapy as an effective tool to treat the resistant cancer cells. Accordingly, in this study, it has been hypothesized that a combination of Vitamin D3(VD) and Itraconazole can inhibit Chronic Myeloid Leukemia(CML) K562 cells in vitro.

Methods and results

K562 cells were incubated with different concentrations of either VD or Itraconazole either alone or in combination. The results showed that Itraconazole, VD, and combination treatment reduced the cell viability in a time and dose-dependent manner (P < 0.0001). In addition, the apoptosis rate was significantly induced in cells treated with combination drug (P < 0.0001). The Bax/Bcl-2 ratio was increased in treated cells, whereas the subcellular distribution of β-catenin protein was reduced. Morever, the phosphorylation of AKT and p65 were increased, whereas AMPK phosphorylation was decreased in treated cells (P < 0.0001).

Conclusion

Our results show that VD and Itraconazole synergically inhibit K562 cells viability via activation of AMPK and suppression of AKT function, suggesting that this combinational therapy potentially benefits CML patients.